Adam Presser

Technician, 2017 – 2020

Undergraduate Degree: Clarkson University

Graduate Degree: Clarkson University

    Adam’s publications from the Sarosiek Laboratory:
AI is a viable alternative to high throughput screening: a 318-target study.
Kristopher Sarosiek, Adam Presser, Xingping Qin, Zintis Inde, Cameron Fraser.
Scientific Reports, 2024 April 02. PubMed. External.
Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics.
Cameron Fraser, Johan Spetz, Xingping Qin, Adam Presser, Jonathan Choiniere, Chendi Li, Stacey Yu, Frances Blevins, Aaron N. Hata, Jeffrey W. Miller, Gary A. Bradshaw,
Marian Kalocsay, Vaishali Sanchorawala, Shayna Sarosiek (co-corresponding author), Kristopher Sarosiek.
Nature Communications, 2022 Oct 2. PDF. Pubmed.
  • Stover EH, Baco MB, Cohen O, Li YY, Christie EL, Bagul M, Goodale A, Lee Y, Pantel S, Rees MG, Wei G, Adam Presser, Gelbard MK, Zhang W, Zervantonakis IK, Bhola PD, Ryan J, Guerriero JL, Montero J, Liang FJ, Cherniack AD, Piccioni F, Matulonis UA, Bowtell DDL, Kristopher Sarosiek, Letai A, Garraway LA, Johannessen CM, Meyerson M.
    Pooled genomic screens identify anti-apoptotic genes as targetable mediators of chemotherapy resistance in ovarian cancer.
    Molecular Cancer Research, 2019 Aug 28. Pubmed.
  • Cameron Fraser, Adam Presser, Vaishali Sanchorawala, Shayna Sarosiek, Kristopher A. Sarosiek.
    Clonal plasma cells in AL amyloidosis are dependent on pro survival BCL-2 family proteins and sensitive to BH3 mimetics (Preprint).
    BioRxiv, February 6 2019. PDF. BioRxiv.
  • Johan Spetz, Adam Presser, Kristopher A. Sarosiek.
    T Cells and Regulated Cell Death: Kill or Be Killed (Review).
    International Review of Cell and Molecular Biology, 2018 September. PDF. Pubmed.